Centene (NYSE:CNC – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 6.800- for the period, compared to the consensus EPS estimate of 6.820. The company issued revenue guidance of $159.0 billion-$161.0 billion, compared to the consensus revenue estimate of $155.6 billion.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on CNC. Wells Fargo & Company reduced their price objective on Centene from $93.00 to $91.00 and set an “overweight” rating for the company in a research note on Friday, September 13th. StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a report on Monday, October 28th. Stephens reiterated an “equal weight” rating and issued a $78.00 target price on shares of Centene in a research report on Monday, August 5th. Cantor Fitzgerald restated an “overweight” rating and set a $90.00 price target on shares of Centene in a report on Tuesday, October 1st. Finally, Oppenheimer cut their price objective on Centene from $110.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, July 29th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $84.00.
Check Out Our Latest Stock Report on CNC
Centene Stock Performance
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Further Reading
- Five stocks we like better than Centene
- Stock Dividend Cuts Happen Are You Ready?
- Battle of the Retailers: Who Comes Out on Top?
- What is Put Option Volume?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- What is the Nikkei 225 index?
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.